BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

BioPharma Pharma & Biopharma Manufacturing

PharmaBlock Sciences Unveils State-of-the-Art High Potency API Facility in Zhejiang Site.

The new HPAPI GMP facility enables PharmaBlock to offer process R&D and kilo-scale production of HPAPIs and ADC toxins. It spans an area of 1...

December 28, 2023 | News

GenSci Launches Global Innovation Hub in Shanghai

Changchun GeneScience Pharmaceutical ("GenSci"), a subsidiary of Changchun High-Tech Industries (Group), held a groundbreaking ceremony for its new global ...

December 26, 2023 | News

Dr. Reddy’s First Indian Pharma Firm to Join Dow Jones Sustainability World Index

In a first for Indian pharma, Dr. Reddy’s is featured in the Dow Jones Sustainability World Index for 2023 Company retains its place in the ...

December 15, 2023 | News

Full-Life Technologies Begins Construction on GMP Manufacturing Facility in Belgium for Radiopharmaceuticals

This strategic investment aims to advance Full-Life's end-to-end solution by enhancing its radiopharmaceutical production capabilities at a key logistical ...

December 08, 2023 | News

GC Biopharma's groundbreaking for the plasma fractionation plant in Indonesia

To commence operation by 2027…with max. 400K liters of plasma production capacity per annum The first step towards localization of ...

December 06, 2023 | News

WuXi Biologics Achieves Breakthrough Productivity of ~6 g/L/day in Integrated Continuous Process at Pilot Scale

By leveraging WuXiUPTM, WuXi Biologics has completed its first end-to-end continuous drug substance (DS) manufacturing from perfused cell culture...

November 23, 2023 | News

SK Bioscience and Hilleman Labs Collaborate on Next-Gen Ebola Vaccine

SK bioscience, an innovative vaccine and biotech company committed to promoting human health from prevention to cure, announced that the company has entere...

November 22, 2023 | News

Lilly to expand injectable manufacturing capacity with planned $2.5 billion site in Germany

Eli Lilly and Company announced plans to construct a new $2.5 billion high-tech manufacturing site in Alzey, Rhineland-Palatinate, Ger...

November 21, 2023 | News

Micron Biomedical Secures $23.6M to Advance Needle-Free Vaccine Production for Measles Eradication

Micron has received this grant from the Bill & Melinda Gates Foundation to fund mass production of needle-free vaccines utilizing Micron technology t...

November 20, 2023 | News

ACROBiosystems Introduces GM-Grade DLL4 Protein for Faster Stem Cell Manufacturing

The availability of DLL4 manufactured under GMP conditions represents a significant milestone for enterprises engaged in developing or manufacturing stem-c...

November 17, 2023 | News

Cytiva Revolutionizes Protein Purification with Universal Affinity Technology

New tag technology is self-cleaving and traceless, helping drug developers and manufacturers obtain pure proteins without remaining tag residues. New af...

November 16, 2023 | News

In Conversation with Eugene Kang: Pioneering the Future of Cell Therapy with Thermo Fisher's CTS Detachable Dynabeads

In an exclusive Q&A by BioPharma APAC with Eugene Kang, Senior Product Manager for Cell Therapy at Thermo Fisher Scientific, we delve into the gr...

November 15, 2023 | News

Telix, an Australian Company, Announces Planned Acquisition of QSAM Biosciences and its Lead Therapy Candidate, CycloSam

CycloSam® is highly synergistic with Telix's existing therapeutic development activity in both prostate cancer and sarcoma. The proposed acquisiti...

November 14, 2023 | News

Hong Chow discusses Merck's ambitious €25 billion sales goal, sustainability initiatives, innovation priorities, and fostering a high-impact culture in the Asia-Pacific region

In an exclusive interview by BioPharma APAC , Hong Chow, Executive Vice President and Head of China & International for Merck's Healthcare business, pr...

November 14, 2023 | News

Stay Connected